EP Patent

EP3316867B1 — Immediate-release tablets containing a drug and processes for forming the tablets

Assigned to Genentech Inc · Expires 2021-03-10 · 5y expired

What this patent protects

Patent listed against cobimetinib-fumarate.

Drugs covered by this patent

cobimetinib-fumarate (COBIMETINIB FUMARATE)

Patent Metadata

Patent number: EP3316867B1
Jurisdiction: EP
Classification: —
Expires: 2021-03-10
Drug substance claim: No
Drug product claim: No
Assignee: Genentech Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.